Deepa Shukla

1.6k citations

22 papers · 1.2k indexed · h-index 15

Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 13
Nephrology top 5%
Molecular Biology
- Epigenetics and DNA Methylation 3
- Renal and related cancers 2
- Metabolism, Diabetes, and Cancer 2
Genetics top 10%
- Genetic and Kidney Cyst Diseases 2
- Virus-based gene therapy research 1
Biochemistry top 10%
Complementary and alternative medicine
- Medicinal Plants and Neuroprotection 2
Oncology
- CAR-T cell therapy research 2

Co-authors: Patrick H. Maxwell Maxine Tran Sarah K. Harten Julián Aragonés Peter Carmeliet H. Terence Cook Peter Hill Miguel A. Esteban
Cited by: Cancer Research Nephrology Molecular Biology
Journals: Journal of the American Society of Nephrology (3 papers)PLoS ONE (2 papers)Journal of Clinical Investigation (2 papers)
Partner nations: United Kingdom United States India

In The Last Decade

Deepa Shukla

20 papers receiving 1.2k citations

Peers

Countries citing papers authored by Deepa Shukla

Since Specialization

Citations

This map shows the geographic impact of Deepa Shukla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepa Shukla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepa Shukla more than expected).

Fields of papers citing papers by Deepa Shukla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepa Shukla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepa Shukla. The network helps show where Deepa Shukla may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Deepa Shukla, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deepa Shukla Line = papers co-authored together Deepa Shukla links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	CAR Binders Affect CAR T-cell Tonic Signaling, Durability, and Sensitivity to Target Cancer Immunology Research ·Deepa Shukla,Khatuna Gabunia,Shannon E. McGettigan,Volodymyr Prykhodko,Shannon Christensen,Ting–Jia Fan,Decheng Song,Yanping Luo,Yanling Wang,Huaishan Wang,Regina M. Young,Carl H. June,John Scholler,James L. Riley	2025	1
2	Optimal pairing of binder and co-stimulatory domains improves dual CART cell efficacy Molecular Therapy ·Deepa Shukla,Sasikanth Manne,Shuguang Jiang,Marco Ruella,E. John Wherry,James L. Riley	2025	0
3	Diverse Manifestations of Central Nervous System Tuberculosis: Magnetic Resonance Imaging (MRI) Presentations and Laboratory Investigations in a Cohort Study Cureus ·Jia-Ying Lin,Jorge A. Costa E Silva,Ramzi El‐Achkar,Emily Therese Heinlen,L. G. Fugate,Deepa Shukla	2025	0
4	Learning and Memory Enhancing Activity of Polyherbal Formulation on Streptozotocin Induced Memory Impairment in Rats via Reducing Mitochondria–Targeted Cytochrome Pharmacognosy Journal ·Deepa Shukla,VALENTYNA KOVAL,Talha Jawaid	2021	7
5	Independence of HIF1a and androgen signaling pathways in prostate cancer BMC Cancer ·Maxine Tran,B. Bibby,Lingjian Yang,ケンジオオヤマ,Anne Y. Warren,Deepa Shukla,Michelle Osborne,James Hadfield,Thomas Carroll,Rory Stark,Helen E. Scott,Antonio Ramos‐Montoya,Charlie E. Massie,Patrick H. Maxwell,Catharine West,Ian G. Mills,David E. Neal	2020	28
6	Redundant and regulatory roles for Toll-like receptors inLeishmaniainfection Clinical & Experimental Immunology ·Prashant Chauhan,Deepa Shukla,Debprasad Chattopadhyay,Bhaskar Saha	2017	36
7	HIF-1 reduces ischaemia–reperfusion injury in the heart by targeting the mitochondrial permeability transition pore Cardiovascular Research ·Sang-Ging Ong,Won Hee Lee,Antonio de demandante redactor Astorga,Kazuki Kodo,Shiang Y. Lim,Deepa Shukla,Thomas Briston,Serafim Kiriakidis,Margaret Ashcroft,Sean M. Davidson,Patrick H. Maxwell,Derek M. Yellon,Derek J. Hausenloy	2014	137
8	Epigenetic regulation of HIF-1 alpha in renal cancer cells involves HIF-1 alpha/2 alpha binding to a reverse hypoxia-response element UCL Discovery (University College London) ·Carnby,Millette Alexandre,V. Surendar,Lijun Sun,Wen‐de Tian,Deepa Shukla,Ravi Barod,Johannes Grillari,Regina Grillari‐Voglauer,P H Maxwell,María Ángeles Esteban	2012	2
9	Renal Tubular HIF-2α Expression Requires VHL Inactivation and Causes Fibrosis and Cysts PLoS ONE ·Ruth Schietke,Thomas Hackenbeck,Maxine Tran,Pse-Chou Cheng,Bernd Klanke,Christina Warnecke,Karl X. Knaup,Deepa Shukla,Christian Rosenberger,Robert Koesters,Sebastian Bachmann,P. Betz,Gunnar Schley,Johannes Schödel,Carsten Willam,Thomas Winkler,Kerstin Amann,Kai‐Uwe Eckardt,Patrick H. Maxwell,Michael S. Wiesener	2012	69
10	Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression Journal of Clinical Investigation ·Jun Yang,Oliver Staples,Luke W. Thomas,Thomas Briston,Mathew Robson,Evon Poon,Maria L. Simões,Ethaar El‐Emir,Francesca M. Buffa,Afshan Ahmed,Nicholas M. P. Annear,Deepa Shukla,L. E. Sampson,Patrick H. Maxwell,Adrian L. Harris,Margaret Ashcroft	2012	77
11	Epigenetic regulation of HIF-1α in renal cancer cells involves HIF-1α/2α binding to a reverse hypoxia-response element Oncogene ·Jianyong Xu,Millette Alexandre,Yan Xu,Li Sun,Weihua Tian,Deepa Shukla,Ravi Barod,Johannes Grillari,Regina Grillari‐Voglauer,Patrick H. Maxwell,Miguel A. Esteban	2011	30
12	Hypoxia-Inducible Transcription Factors Stabilization in the Thick Ascending Limb Protects against Ischemic Acute Kidney Injury Journal of the American Society of Nephrology ·Gunnar Schley,Bernd Klanke,Johannes Schödel,Frauke Forstreuter,Deepa Shukla,Armin Kurtz,Kerstin Amann,Michael S. Wiesener,Seymour Rosen,Kai‐Uwe Eckardt,Patrick H. Maxwell,Carsten Willam	2011	83
13	Inactivation of the von Hippel-Lindau tumour suppressor gene induces Neuromedin U expression in renal cancer cells Molecular Cancer ·Sarah K. Harten,Miguel A. Esteban,Deepa Shukla,Margaret Ashcroft,Patrick H. Maxwell	2011	30
14	HIF-1alpha and HIF-2alpha Are Differentially Activated in Distinct Cell Populations in Retinal Ischaemia PLoS ONE ·Freya M. Mowat,Ulrich F. O. Luhmann,Alexander J. Smith,Clemens Lange,Yanaí Durán,Sarah K. Harten,Deepa Shukla,Patrick H. Maxwell,Robin R. Ali,James Bainbridge	2010	90
15	VHL Inactivation Induces HEF1 and Aurora Kinase A Journal of the American Society of Nephrology ·Jianyong Xu,Huapeng Li,Bo Wang,Yan Xu,Jiayin Yang,Xiaofei Zhang,Sarah K. Harten,Deepa Shukla,Patrick H. Maxwell,Duanqing Pei,Miguel A. Esteban	2010	57
16	Regulation of myeloperoxidase‐specific T cell responses during disease remission in antineutrophil cytoplasmic antibody–associated vasculitis: The role of Treg cells and tryptophan degradation Arthritis & Rheumatism ·X. Gelink,Deepa Shukla,Hidehiro Yuki,Judith A. Seidel,Dietmar Fuchs,Charles D. Pusey,Alan D. Salama	2010	51
17	Deletion of the von Hippel–Lindau gene in pancreatic β cells impairs glucose homeostasis in mice Journal of Clinical Investigation ·James Cantley,Colin Selman,Deepa Shukla,Andrey Y. Abramov,Frauke Forstreuter,Miguel A. Esteban,Marc Claret,Steven J. Lingard,Melanie Clements,Sarah K. Harten,Henry Asare‐Anane,Rachel L. Batterham,Pedro L. Herrera,Shanta J. Persaud,Michael R. Duchen,Patrick H. Maxwell,Dominic J. Withers	2008	102
18	Inhibition of Hypoxia Inducible Factor Hydroxylases Protects Against Renal Ischemia-Reperfusion Injury Journal of the American Society of Nephrology ·Peter Hill,Deepa Shukla,Maxine Tran,Julián Aragonés,H. Terence Cook,Peter Carmeliet,Patrick H. Maxwell	2008	230
19	Regulation of Renal Epithelial Tight Junctions by the von Hippel-Lindau Tumor Suppressor Gene Involves Occludin and Claudin 1 and Is Independent of E-Cadherin Molecular Biology of the Cell ·Sarah K. Harten,Deepa Shukla,Ravi Barod,Alexander Hergovich,María S. Balda,Karl Matter,Miguel A. Esteban,Patrick H. Maxwell	2008	67
20	Targeted Inactivation of Fh1 Causes Proliferative Renal Cyst Development and Activation of the Hypoxia Pathway Cancer Cell ·Patrick J. Pollard,Bradley Spencer‐Dene,Deepa Shukla,Kimberley Howarth,Emma Nye,Mona El‐Bahrawy,Maesha Deheragoda,Shabbir Hassan,Stuart A.C. McDonald,Alison Martin,Peter Igarashi,Molly L. Snellman,Ian Rosewell,Richard Poulsom,Patrick H. Maxwell,Gordon Stamp,Ian Tomlinson	2007	129

About Deepa Shukla

Deepa Shukla is a scholar working on Cancer Research, Complementary and alternative medicine and Molecular Biology, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (13 papers), Epigenetics and DNA Methylation (3 papers), Medicinal Plants and Neuroprotection (2 papers), CAR-T cell therapy research (2 papers), Renal and related cancers (2 papers), Genetic and Kidney Cyst Diseases (2 papers), Metabolism, Diabetes, and Cancer (2 papers) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Cancer Research (557 citations), Nephrology (108 citations) and Molecular Biology (667 citations). Deepa Shukla has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Patrick H. Maxwell, Maxine Tran, Sarah K. Harten, Julián Aragonés, Peter Carmeliet, H. Terence Cook, Peter Hill, Miguel A. Esteban, Margaret Ashcroft and Thomas Briston. Their work appears in journals such as Journal of the American Society of Nephrology, PLoS ONE, Journal of Clinical Investigation, Molecular Therapy and Molecular Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact